Skip to main content
Top
Published in: Cancer Causes & Control 3/2016

01-03-2016 | Original paper

Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC)

Authors: Cheryl Vigen, Marilyn L. Kwan, Esther M. John, Scarlett Lin Gomez, Theresa H. M. Keegan, Yani Lu, Salma Shariff-Marco, Kristine R. Monroe, Allison W. Kurian, Iona Cheng, Bette J. Caan, Valerie S. Lee, Janise M. Roh, Leslie Bernstein, Richard Sposto, Anna H. Wu

Published in: Cancer Causes & Control | Issue 3/2016

Login to get access

Abstract

Purpose

To compare information from self-report and electronic medical records for four common comorbidities (diabetes, hypertension, myocardial infarction, and other heart diseases).

Methods

We pooled data from two multiethnic studies (one case–control and one survivor cohort) enrolling 1,936 women diagnosed with breast cancer, who were members of Kaiser Permanente Northern California.

Results

Concordance varied by comorbidity; kappa values ranged from 0.50 for other heart diseases to 0.87 for diabetes. Sensitivities for comorbidities from self-report versus medical record were similar for racial/ethnic minorities and non-Hispanic Whites, and did not vary by age, neighborhood socioeconomic status, or education. Women with a longer history of comorbidity or who took medications for the comorbidity were more likely to report the condition. Hazard ratios for all-cause mortality were not consistently affected by source of comorbidity information; the hazard ratio was lower for diabetes, but higher for the other comorbidities when medical record versus self-report was used. Model fit was better when the medical record versus self-reported data were used.

Conclusions

Comorbidities are increasingly recognized to influence the survival of patients with breast or other cancers. Potential effects of misclassification of comorbidity status should be considered in the interpretation of research results.
Literature
1.
go back to reference Patnaik JL, Byers T, DiGuiseppi C, Denberg TD, Dabelea D (2011) The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 103(14):1101–1111PubMedCentralCrossRefPubMed Patnaik JL, Byers T, DiGuiseppi C, Denberg TD, Dabelea D (2011) The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 103(14):1101–1111PubMedCentralCrossRefPubMed
2.
go back to reference Land LH, Dalton SO, Jorgensen TL, Ewertz M (2012) Comorbidity and survival after early breast cancer. A review. Crit Rev Oncol Hematol 81(2):196–205CrossRefPubMed Land LH, Dalton SO, Jorgensen TL, Ewertz M (2012) Comorbidity and survival after early breast cancer. A review. Crit Rev Oncol Hematol 81(2):196–205CrossRefPubMed
3.
go back to reference Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D (2005) Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294(14):1765–1772CrossRefPubMed Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D (2005) Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294(14):1765–1772CrossRefPubMed
4.
go back to reference Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L (2009) Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer 124(5):1213–1219CrossRefPubMed Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L (2009) Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer 124(5):1213–1219CrossRefPubMed
5.
go back to reference Du W, Simon MS (2005) Racial disparities in treatment and survival of women with stage I–III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat 91(3):243–248CrossRefPubMed Du W, Simon MS (2005) Racial disparities in treatment and survival of women with stage I–III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat 91(3):243–248CrossRefPubMed
6.
go back to reference Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2008) The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 109(2):389–395CrossRefPubMed Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2008) The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 109(2):389–395CrossRefPubMed
7.
go back to reference Louwman WJ, Janssen-Heijnen ML, Houterman S, Voogd AC, van der Sangen MJ, Nieuwenhuijzen GA, Coebergh JW (2005) Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41(5):779–785CrossRefPubMed Louwman WJ, Janssen-Heijnen ML, Houterman S, Voogd AC, van der Sangen MJ, Nieuwenhuijzen GA, Coebergh JW (2005) Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41(5):779–785CrossRefPubMed
8.
go back to reference Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285(7):885–892CrossRefPubMed Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285(7):885–892CrossRefPubMed
9.
go back to reference Patterson RE, Flatt SW, Saquib N, Rock CL, Caan BJ, Parker BA, Laughlin GA, Erickson K, Thomson CA, Bardwell WA, Hajek RA, Pierce JP (2010) Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 122(3):859–865PubMedCentralCrossRefPubMed Patterson RE, Flatt SW, Saquib N, Rock CL, Caan BJ, Parker BA, Laughlin GA, Erickson K, Thomson CA, Bardwell WA, Hajek RA, Pierce JP (2010) Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 122(3):859–865PubMedCentralCrossRefPubMed
10.
go back to reference Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD (2011) Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 13(3):R64PubMedCentralCrossRefPubMed Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD (2011) Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 13(3):R64PubMedCentralCrossRefPubMed
11.
go back to reference Nechuta S, Lu W, Zheng Y, Cai H, Bao PP, Gu K, Zheng W, Shu XO (2013) Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study. Breast Cancer Res Treat 139(1):227–235PubMedCentralCrossRefPubMed Nechuta S, Lu W, Zheng Y, Cai H, Bao PP, Gu K, Zheng W, Shu XO (2013) Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study. Breast Cancer Res Treat 139(1):227–235PubMedCentralCrossRefPubMed
12.
go back to reference Wu AH, Kurian AW, Kwan ML, John EM, Lu Y, Keegan TH, Gomez SL, Cheng I, Shariff-Marco S, Caan BJ, Lee VS, Sullivan-Halley J, Tseng CC, Bernstein L, Sposto R, Vigen C (2015) Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomarkers Prev 24(2):361–368PubMedCentralCrossRefPubMed Wu AH, Kurian AW, Kwan ML, John EM, Lu Y, Keegan TH, Gomez SL, Cheng I, Shariff-Marco S, Caan BJ, Lee VS, Sullivan-Halley J, Tseng CC, Bernstein L, Sposto R, Vigen C (2015) Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomarkers Prev 24(2):361–368PubMedCentralCrossRefPubMed
13.
go back to reference Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Care Res 49(2):156–163CrossRef Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Care Res 49(2):156–163CrossRef
14.
go back to reference Martin LM, Leff M, Calonge N, Garrett C, Nelson DE (2000) Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 18(3):215–218CrossRefPubMed Martin LM, Leff M, Calonge N, Garrett C, Nelson DE (2000) Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 18(3):215–218CrossRefPubMed
15.
go back to reference Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ (2004) Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57(10):1096–1103CrossRefPubMed Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ (2004) Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57(10):1096–1103CrossRefPubMed
16.
go back to reference Baena-Díez JM, Alzamora-Sas MT, Grau M, Subirana I, Vila J, Torán P, García-Navarro Y, Bermúdez-Chillida N, Alegre-Basagaña J, Viozquez-Meia M (2009) Validity of the MONICA cardiovascular questionnaire compared with clinical records. Gac Sanit 23(6):519–525CrossRefPubMed Baena-Díez JM, Alzamora-Sas MT, Grau M, Subirana I, Vila J, Torán P, García-Navarro Y, Bermúdez-Chillida N, Alegre-Basagaña J, Viozquez-Meia M (2009) Validity of the MONICA cardiovascular questionnaire compared with clinical records. Gac Sanit 23(6):519–525CrossRefPubMed
17.
go back to reference Merkin SS, Cavanaugh K, Longenecker JC, Fink NE, Levey AS, Powe NR (2007) Agreement of self-reported comorbid conditions with medical and physician reports varied by disease among end-stage renal disease patients. J Clin Epidemiol 60(6):634–642PubMedCentralCrossRefPubMed Merkin SS, Cavanaugh K, Longenecker JC, Fink NE, Levey AS, Powe NR (2007) Agreement of self-reported comorbid conditions with medical and physician reports varied by disease among end-stage renal disease patients. J Clin Epidemiol 60(6):634–642PubMedCentralCrossRefPubMed
18.
go back to reference Haapanen N, Miilunpalo S, Pasanen M, Oja P, Vuori I (1997) Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. Am J Epidemiol 45(8):762–769CrossRef Haapanen N, Miilunpalo S, Pasanen M, Oja P, Vuori I (1997) Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. Am J Epidemiol 45(8):762–769CrossRef
19.
go back to reference Corser W, Sikorskii A, Olomu A, Stommel M, Proden C, Holmes-Rovner M (2008) Concordance between comorbidity data from patient self-report interviews and medical record documentation. BMC Health Serv Res 8(1):85PubMedCentralCrossRefPubMed Corser W, Sikorskii A, Olomu A, Stommel M, Proden C, Holmes-Rovner M (2008) Concordance between comorbidity data from patient self-report interviews and medical record documentation. BMC Health Serv Res 8(1):85PubMedCentralCrossRefPubMed
20.
go back to reference Eze-Nliam C, Cain K, Bond K, Forlenza K, Jankowski R, Magyar-Russell G, Yenokyan G, Ziegelstein RC (2012) Discrepancies between the medical record and the reports of patients with acute coronary syndrome regarding important aspects of the medical history. BMC Health Serv Res 12(1):78PubMedCentralCrossRefPubMed Eze-Nliam C, Cain K, Bond K, Forlenza K, Jankowski R, Magyar-Russell G, Yenokyan G, Ziegelstein RC (2012) Discrepancies between the medical record and the reports of patients with acute coronary syndrome regarding important aspects of the medical history. BMC Health Serv Res 12(1):78PubMedCentralCrossRefPubMed
21.
go back to reference Midthjell K, Holmen J, Bjorndal A, Lund-Larsen G (1992) Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trondelag diabetes study. J Epidemiol Commun Health 46(5):537–542CrossRef Midthjell K, Holmen J, Bjorndal A, Lund-Larsen G (1992) Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trondelag diabetes study. J Epidemiol Commun Health 46(5):537–542CrossRef
22.
go back to reference Skinner KM, Miller DR, Lincoln E, Lee A, Kazis LE (2005) Concordance between respondent self-reports and medical records for chronic conditions: experience from the Veterans Health Study. J Ambulat Care Manag 28(2):102–110CrossRef Skinner KM, Miller DR, Lincoln E, Lee A, Kazis LE (2005) Concordance between respondent self-reports and medical records for chronic conditions: experience from the Veterans Health Study. J Ambulat Care Manag 28(2):102–110CrossRef
24.
go back to reference Kwan ML, John EM, Caan BJ, Lee VS, Bernstein L, Cheng I, Gomez SL, Henderson BE, Keegan TH, Kurian AW, Lu Y, Monroe KR, Roh JM, Shariff-Marco S, Sposto R, Vigen C, Wu AH (2014) Obesity and mortality after breast cancer by race/ethnicity: the California Breast Cancer Survivorship Consortium. Am J Epidemiol 179(1):95–111PubMedCentralCrossRefPubMed Kwan ML, John EM, Caan BJ, Lee VS, Bernstein L, Cheng I, Gomez SL, Henderson BE, Keegan TH, Kurian AW, Lu Y, Monroe KR, Roh JM, Shariff-Marco S, Sposto R, Vigen C, Wu AH (2014) Obesity and mortality after breast cancer by race/ethnicity: the California Breast Cancer Survivorship Consortium. Am J Epidemiol 179(1):95–111PubMedCentralCrossRefPubMed
25.
go back to reference Lu Y, John EM, Sullivan-Halley J, Vigen C, Gomez SL, Kwan ML, Caan BJ, Lee VS, Roh JM, Shariff-Marco S, Keegan TH, Kurian AW, Monroe KR, Cheng I, Sposto R, Wu AH, Bernstein L (2015) History of recreational physical activity and survival after breast cancer: the California Breast Cancer Survivorship Consortium. Am J Epidemiol 181(12):944–955CrossRefPubMed Lu Y, John EM, Sullivan-Halley J, Vigen C, Gomez SL, Kwan ML, Caan BJ, Lee VS, Roh JM, Shariff-Marco S, Keegan TH, Kurian AW, Monroe KR, Cheng I, Sposto R, Wu AH, Bernstein L (2015) History of recreational physical activity and survival after breast cancer: the California Breast Cancer Survivorship Consortium. Am J Epidemiol 181(12):944–955CrossRefPubMed
26.
go back to reference Wu AH, Gomez SL, Vigen C, Kwan ML, Keegan TH, Lu Y, Shariff-Marco S, Monroe KR, Kurian AW, Cheng I, Caan BJ, Lee VS, Roh JM, Sullivan-Halley J, Henderson BE, Bernstein L, John EM, Sposto R (2013) The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. Cancer Causes Control 24(10):1821–1836PubMedCentralCrossRefPubMed Wu AH, Gomez SL, Vigen C, Kwan ML, Keegan TH, Lu Y, Shariff-Marco S, Monroe KR, Kurian AW, Cheng I, Caan BJ, Lee VS, Roh JM, Sullivan-Halley J, Henderson BE, Bernstein L, John EM, Sposto R (2013) The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. Cancer Causes Control 24(10):1821–1836PubMedCentralCrossRefPubMed
27.
go back to reference John EM, Phipps AI, Davis A, Koo J (2005) Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomark Prev 14(12):2905–2913CrossRef John EM, Phipps AI, Davis A, Koo J (2005) Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomark Prev 14(12):2905–2913CrossRef
28.
go back to reference Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML (2005) Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control 16(5):545–556CrossRefPubMed Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML (2005) Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control 16(5):545–556CrossRefPubMed
29.
go back to reference Ross M, Tyler R, Ng M, Jeffrey S, Mark C, Hart M, John F (2014) The HMO research network virtual data warehouse: a public data model to support collaboration. eGEMs 2(1):2 Ross M, Tyler R, Ng M, Jeffrey S, Mark C, Hart M, John F (2014) The HMO research network virtual data warehouse: a public data model to support collaboration. eGEMs 2(1):2
30.
go back to reference Viera AJ, Garrett JM (2005) Understanding interobserver agreement: the kappa statistic. Fam Med 37(5):360–363PubMed Viera AJ, Garrett JM (2005) Understanding interobserver agreement: the kappa statistic. Fam Med 37(5):360–363PubMed
31.
go back to reference Yost K, Perkins C, Cohen R, Morris C, Wright W (2001) Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12(8):703–711CrossRefPubMed Yost K, Perkins C, Cohen R, Morris C, Wright W (2001) Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12(8):703–711CrossRefPubMed
Metadata
Title
Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC)
Authors
Cheryl Vigen
Marilyn L. Kwan
Esther M. John
Scarlett Lin Gomez
Theresa H. M. Keegan
Yani Lu
Salma Shariff-Marco
Kristine R. Monroe
Allison W. Kurian
Iona Cheng
Bette J. Caan
Valerie S. Lee
Janise M. Roh
Leslie Bernstein
Richard Sposto
Anna H. Wu
Publication date
01-03-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 3/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0715-8

Other articles of this Issue 3/2016

Cancer Causes & Control 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine